Content type

Drugmaker Investments Will Boost Singapore’s Pharmaceutical Sector, Reflecting Robust Investor Confidence

Pharmaceuticals / Singapore / Thu 23 May, 2024

Key View:

  • Ongoing drugmaker investment will boost Singapore’s status as a key pharmaceutical hub.
  • The government of Singapore will continue to take a proactive role in developing the market’s biomedical manufacturing industry. 
  • Through AstraZeneca’s investment, Singapore's position as an important trading hub for the pharmaceutical sector in the
Read More

Singapore Seeking To Position Itself As A Two-Way LNG Trader

Oil & Gas / Singapore / Mon 20 May, 2024

Key View

  • Singapore's LNG imports are set to rise as the country prepares to build a second import terminal.
  • LNG demand is set to grow further in 2024 and beyond as Singapore’s government seeks to achieve carbon emission reduction targets.
  • LNG bunker sales in the short term are expected to grow faster compared to other sectors.
  • Given its well
Read More

Singapore's Medical Devices Market Growth Will Be Driven By Ongoing Government Support And An Ageing Population

Medical Devices / Singapore / Fri 09 Feb, 2024

Key View

  • Singapore’s commitment to addressing the healthcare needs of its ageing population will support medical devices market growth over the medium term, despite economic pressure. 
  • The Ministry of Health's implementation of a more value-based subsidy framework will expand access and affordability of certain devices, however may create
Read More

Quick View: Abbvie’s Expansion In Singapore Will Bolster Its Global Biopharmaceutical Supply Capabilities

Pharmaceuticals / Singapore / Thu 01 Feb, 2024

The Latest: On January 29 2024, AbbVie announced a major expansion initiative for its manufacturing operations in Singapore with an investment of USD223mn. This strategic infusion of capital is intended to bolster AbbVie's worldwide production network with an emphasis on the development of biologic drugs. The planned expansion will not only

Read More

Singapore Not Likely To See Another Bumper Year For FDI

Country Risk / Singapore / Thu 18 Jan, 2024

Key View

  • We expect inward FDI to fall below 30% of GDP in 2023 and 2024.
  • A jump in retained earnings were behind the FDI increase in 2021 and 2022, and they notably did little to boost economic growth in Singapore.
  • The expected reduction in inward FDI will not pose risks to Singapore’s external balance, given ample foreign reserves and
Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.